생체흡수성 스캐폴드 시장 규모, 점유율, 성장 분석 : 재료 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Bioresorbable Scaffolds Market size was valued at USD 2.04 Billion in 2024 and is poised to grow from USD 2.44 Billion in 2025 to USD 10.14 Billion by 2033, growing at a CAGR of 19.5% during the forecast period (2026-2033).

The bioresorbable scaffolds market is experiencing robust growth driven by advancements in medical technology and a surge in cardiovascular disease prevalence. These temporary implants promote natural vessel healing by gradually dissolving over time, with the market segmented into material type, application, end-user, and region. Polymer-based scaffolds lead due to their biocompatibility and resorption characteristics, while applications are primarily centered on cardiovascular diseases, which dominate demand. Hospitals, ambulatory surgical centers, and specialized clinics serve as key end-users, fueled by increasing cardiac intervention admissions. North America holds a significant share, supported by advanced healthcare infrastructure, followed by Europe's research initiatives and the Asia-Pacific region's growing investments. Although challenges like high costs exist, ongoing research is expected to bolster market growth in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioresorbable Scaffolds Market Segments Analysis

Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioresorbable Scaffolds Market

The increasing incidence of cardiovascular conditions, including coronary artery disease and peripheral artery disease, significantly fuels the growth of the bioresorbable scaffolds market. As these health issues become more common, there is an urgent need for effective treatment options that can restore proper blood flow. This rising demand encourages the development of innovative medical solutions, particularly bioresorbable scaffolds, which offer promising results in managing these complex cardiovascular conditions. The continuous search for improved therapeutic approaches in the face of these prevalent disorders is thus a fundamental factor driving the bioresorbable scaffolds market forward.

Restraints in the Bioresorbable Scaffolds Market

The bioresorbable scaffolds market encounters significant obstacles due to a scarcity of long-term clinical evidence. There is a pressing need for comprehensive assessments comparing the performance of bioresorbable scaffold implants with that of conventional stents. Without this crucial evaluation, it remains difficult to definitively establish the efficacy and safety of bioresorbable scaffolds. This lack of robust clinical data hinders the market's growth, as healthcare providers may be hesitant to adopt these innovative solutions without clear evidence of their advantages over traditional options. Consequently, addressing this issue is vital for the future advancement of the bioresorbable scaffolds market.

Market Trends of the Bioresorbable Scaffolds Market

The demand for bioresorbable scaffolds is witnessing a significant upward trend, largely propelled by the rise of the geriatric population, which necessitates enhanced healthcare solutions. As older individuals become more prone to cardiovascular diseases, the requirement for effective and innovative treatment options intensifies. Bioresorbable scaffolds, known for their ability to dissolve within the body post-treatment, are increasingly favored for their potential to reduce long-term complications associated with permanent devices. This shift towards less invasive, temporary solutions reflects a broader movement in healthcare, as providers aim to meet the unique needs of aging patients while continually improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Polymer-based Scaffolds
• Metallic Scaffolds

Global Bioresorbable Scaffolds Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease
• Peripheral Artery Disease

Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

Global Bioresorbable Scaffolds Market Size & CAGR (2026-2033)

• North America (Material Type, Application, End-user)
  • US
  • Canada
• Europe (Material Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S3V Vascular Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zorion Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenogenics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMT (Sahajanand Medical Technologies) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations